FDA Authorizes Pfizer-BioNTech Vaccine for Young Children

(from the New York Times) The Food and Drug Administration on Friday authorized Pfizer-BioNTech’s coronavirus vaccine for emergency use in children 5 to 11, a move eagerly anticipated by millions of families looking to protect some of the only remaining Americans left out of the vaccination campaign. About 28 million children in the group are now eligible to receive one-third of the adult dose, with two injections three weeks apart. If the Centers for Disease Control and Prevention signs off, as is expected, they could start getting shots as early as Wednesday. 

More from the New York Times

Related content
COVID-19 Vaccine Boosters & Independent Schools